{{Rsnum
|rsid=6712932
|Chromosome=2
|position=105221141
|Orientation=plus
|GMAF=0.2819
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.5 | 42.0 | 45.5
| HCB | 6.6 | 29.9 | 63.5
| JPT | 4.4 | 38.9 | 56.6
| YRI | 9.8 | 36.4 | 53.8
| ASW | 7.0 | 50.9 | 42.1
| CHB | 6.6 | 29.9 | 63.5
| CHD | 9.3 | 35.2 | 55.6
| GIH | 11.0 | 43.0 | 46.0
| LWK | 2.8 | 40.4 | 56.9
| MEX | 6.9 | 48.3 | 44.8
| MKK | 5.9 | 45.1 | 49.0
| TSI | 13.7 | 47.1 | 39.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=17668382
|Trait=Type 2 diabetes
|Title=Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium
|RiskAllele=
|Pval=0.0000060000000000000002
|OR=1.52
|ORtxt=[1.27-1.82]
|OA=1
}}

{{PharmGKB
|RSID=rs6712932
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17668382; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. (Initial Sample Size: 500 cases, 497 controls; Replication Sample Size: 2,573 cases, 2,776 controls); (Region: 2q12.1; Reported Gene(s): Intergenic; Risk Allele: rs6712932-?); (p-value= 0.000006).This variant is associated with Type 2 diabetes.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus; Diabetes Mellitus, Type 2
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740865
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6712932
|overall_frequency_n=49
|overall_frequency_d=128
|overall_frequency=0.382812
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=45
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}